AzTrials
AzTrials

Spinal Cord InjuriesNCT05094362

Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning

A study testing Spinal Reflex Operant Down Conditioning in people with Spinal Cord Injuries and Neurological Injury, run by Medical University of South Carolina at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to validate the capacity of a reflex training system to change the size of the targeted reflex. For this, the researchers are recruiting 25 individuals with chronic incomplete SCI who have spasticity in the leg to participate in the reflex training procedure. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Spinal Reflex Operant Down Conditioning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
2 sitesUnited States
Study dates
23 Aug 2023to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a clinically stable spinal cord injury (above T11) that occurred at least one year previously
  • the ability to ambulate at least 10 m with or without an assistive device (i.e., walker, crutches, or cane, not parallel bars) within 100 sec (those with 10-meter walking time >100 sec are excluded because it is unlikely that they are able to participate in and complete our planned locomotion evaluation procedures)
  • clinical signs of spasticity in the plantarflexor muscles at least unilaterally (i.e., hyperreactivity to Achilles tendon tap, and increased muscle tone, score >1 on Modified Ashworth scale)
  • spastic hyperreflexia reflected in exaggerated H-reflex
  • functionally and medically stable for at least 3 months
  • medical clearance to participate
  • reasonable expectation that current medications (including antispasticity medication such as baclofen, diazepam, and tizanidine) will not change over the conditioning period. Each participant's medication and dosage will be monitored and recorded throughout the study. Once enrolled, the subject will remain enrolled even if medication changes. (Because only neurologically stable subjects will enter this study, medication changes will be unlikely.)

Who cannot join

  • motoneuron injury;
  • a cardiac condition (history of myocardial infarct, pacemaker use, etc.)
  • an unstable medical condition
  • a pre-existing or confounding neurological condition (e.g., history of Multiple Sclerosis (MS), Traumatic Brain Injury (TBI), Stroke, Parkinson's disease)
  • a condition that prevents lower extremity mobility testing or weight bearing (e.g. fracture, severe sprain/strain, botox muscular injection) (orthotic knee hyperextension is not excluded; in severe cases of knee hyperextension, the brace can be worn during the study sessions)
  • a cognitive impairment that precludes giving informed consent (e.g., severe intellectual disability)
Show all 10Show fewer
  • use of a functional electrical stimulation (FES) foot-drop stimulator or an FES bicycle on a daily basis (FES applied to the arm is acceptable)
  • deep vein thrombosis within the past 6 months
  • depression (due to potential interference of anti-depressant medication with the intervention and possible reduced participation reliability)
  • pregnancy (due to expected changes in weight and posture and potentially unstable medical condition).

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Blair Dellenbach, MSOT contact

843-792-6313

stecb@musc.edu

United States2 sites, 2 recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, 29425

    Blair Dellenbach, MSOT, 843-792-6313, stecb@musc.edu

    Not yet recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, 29425

    Blair Dellenbach, MSOT, 843-792-6313, stecb@musc.edu

    Recruiting

Other trials in United States

About this study

Official title: Operant Conditioning of Spinal Reflexes to Enhance Motor Function Recovery After Spinal Cord Injury

The purpose of this study is to validate the capacity of a reflex training system to change the size of the targeted reflex. For this, the researchers are recruiting 25 individuals with chronic incomplete SCI who have spasticity in the leg to participate in the reflex training procedure. The study involves approximately 45 visits with a total study duration of about 6 months.

Being tested
Spinal Reflex Operant Down Conditioning
Keywords
Neuroplasticity, Spinal Reflex
Medical subject headings
Spinal Cord Injuries, Trauma, Nervous System, Paralysis, Muscle Spasticity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal Reflex Operant Down ConditioningBehavioural

    This is a training intervention in which people with a spinal cord injury are trained to reduce the activity of a certain spinal reflex. By decreasing this reflex, individuals decrease hyperactivity in the reflex and can reduce spasticity.

Study groups in NCT05094362
Study groupRoleWhat they receive
Validation of the new training systemExperimentalThe researchers will measure changes in H-reflex size achieved with the use of the new system and compare these measures with the existing results in 25 spastic individuals with chronic incomplete SCI. Each participant completes 6 baseline sessions and 30 conditioning sessions. In the 30 conditioning sessions, the soleus H-reflex will be down-conditioned to decrease the activity of the hyperactive spinal stretch reflex pathway in people with spasticity that is characterized by exaggerated reflex activity. It is anticipated that the magnitude of reflex change obtained with the use of the new system would be greater or at least the same as the bench-marked values from the previous studies that used the old prototype reflex conditioning system.
Receives: Behavioral: Spinal Reflex Operant Down Conditioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation

    Decreased H-reflex amplitude indicates reduced reflex activity and a more normal reflex response to muscle activity

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  2. Change in walking speed (m/s) as measured by the 10-meter Walk Test (10MWT)

    Speed of the participant's fastest comfortable walking speed across 10 meters. Decreased time (sec) demonstrates increased walking speed (m/s)

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  3. Change in walking distance (meters) as measured by the 6-minute walk test

    The distance walked in 6 minutes in measured. The participant is asked to walk at his/her fastest comfortable speed on an indoor walkway.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

Secondary outcomes (8)
  1. Change in the level of assistance required to walk 10 meters as measured by the Walking Index for Spinal Cord Injury (WI-SCI)

    WI-SCI classifies the level of assistance needed to perform the 10MWT; the scale is from 0-20 with 20 being no assistance required at all. An increase of score indicates increased level of independence while walking.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  2. Change in level of spasticity in the more affected leg as measured by the Modified Ashworth Scale (MAS)

    A decrease in the score on the MAS indicates a decrease in spasticity. To measure spasticity, resistance to passive movement about a joint is tested at a range of velocities. The score ranges from 0-4 (i.e., 0: normal muscle tone; 4: rigid in flexion or extension).

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  3. Change in balance as measured by Berg Balance Scale

    An increase in score on the Berg Balance scale indicates better balance and decreased fall risk. For each item, the score ranges from 0-4 with a maximum total score of 56.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  4. Change in basic functional independence as measured by the Spinal Cord Independence Measure (SCIM III)

    An increase in the the score on the SCIM III indicates increased basic functional independence. This is a self report questionnaire with 19 items in three sub-scales: (1) self-care (6 items, subscore 0-20); (2) respiration and sphincter management (4 items, subscore 0-40); and (3) mobility (9 items, subscore 0-40). The total score ranges from 0-100.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  5. Change in functional independence as measured by the Functional Independence Measure (FIM)

    An increase in the score on the FIM indicates and increase in functional independence. This 18-item, clinician-reported scale assesses function in 6 areas including self-care, continence, mobility, transfers, communication, and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1 = total assistance required, 7 = complete independence).

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  6. Change in quality of life as measured by Spinal Cord Injury Quality of Life and Participation Questionnaire (SCI-QOL)

    An increase in score on the SCI-QOL indicates an increase in quality of life.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  7. Change is strength of key muscles in the lower extremity as measured by Manual Muscle Testing (MMT)

    To test the strength against the examiner's resistance and grading the patient's strength on a 0 to 5 scale. 0: No muscle activation; 1: Trace muscle activation, such as a twitch, without achieving full range of motion; 2: Muscle activation with gravity eliminated, achieving full range of motion; 3: Muscle activation against gravity, full range of motion; 4: Muscle activation against some resistance, full range of motion; 5: Muscle activation against examiner's full resistance, full range of motion.

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

  8. Change in dynamic and static muscle length and joint range of motion (ROM) as measured by Tardieu Scale

    An increase in joint range of motion (deg) indicates ROM more similar to individuals without injury

    Measured: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start23 Aug 2023
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05094362
Sponsor's protocol ID
00095583
Other IDs
4U44NS114420-03
Status last verified
Sep 2026
First submitted
14 Oct 2021
Last updated
15 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Spinal Reflex Operant Down Conditioning in people with Spinal Cord Injuries and Neurological Injury, run by Medical University of South Carolina at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Blair Dellenbach, MSOT (843-792-6313, stecb@musc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation (time frame: Before Baseline, after completion of intervention sessions (approximately 10 weeks), 1 month and 3 months after the completion of intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in